Search - tctmd.com

Displaying 141 - 160 of 196

Sort: Relevancy | Date

Presentation SCAI 2018

Cerebral Embolic Protection: Protect Everyone

Presenter: Samir Kapadia

April 28, 2018

Presentation SCAI 2018

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Presenter: Steven J Yakubov

April 28, 2018

News Conference News SCAI 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Shelley Wood

April 28, 2018

Update on Mitral Valve Disease and Transcatheter Therapies for Non-Aortic Valves

Presentation Fellows 2018

Cerebral Embolic Protection: A New Standard of Care?

Presenter: Susheel K. Kodali

April 15, 2018

Presentation JIM 2018

The EMBLOK Embolic Protection System Early Feasibility and Safety Study: Preliminary Results

Presenter: Azeem Latib

February 23, 2018

Presentation JIM 2018

Prime Time For..."Protected TAVI"

Presenter: Martin B. Leon

February 23, 2018

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Caitlin E. Cox

February 05, 2018

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Presenter: Martin B. Leon, Changfu Wu, John C Laschinger

October 31, 2017

Presentation TCT 2017

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

Presenter: Martin B. Leon, Changfu Wu

October 31, 2017

Presentation TCT 2017

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Presenter: Reginald I. Low, Michael J. Rinaldi, Julia Seeger

October 31, 2017

Presentation TCT 2017

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

Presenter: Dariusz Dudek, Martin Hudec, Julia Seeger

October 30, 2017

Presentation

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll,

October 06, 2017

Presentation CDM 2017

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll

October 06, 2017

Manuscript

Cerebral Embolic Protection: Point–Counter Point

September 08, 2017

Manuscript

Cerebral Embolic Protection: Not Enough Evidence to Support Routine Clinical Use

August 14, 2017

Podcast

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

August 10, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

Advertisement

Cerebral Embolic Protection: Protect Everyone

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Cerebral Embolic Protection: A New Standard of Care?

The EMBLOK Embolic Protection System Early Feasibility and Safety Study: Preliminary Results

Prime Time For..."Protected TAVI"

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Embolic Protection Devices For TAVR Procedures: Lessons Learned From SENTINEL and Other Experiences

TCT 36: Cerebral Embolic Protection During Transfemoral Aortic Valve Replacement Reduces Death and Stroke Compared to Unprotected Procedure in All Subgroups

Germany Presents: Case Introduction - TAVR in a Low-Risk Patient With Cerebral Embolic Protection

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Cerebral Embolic Protection: Point–Counter Point

Cerebral Embolic Protection: Not Enough Evidence to Support Routine Clinical Use

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content